Influence of heparin on serum free thyroxine. 1969

D L Schatz, and R H Sheppard, and G Steiner, and C S Chandarlapaty, and G A de Veber

UI MeSH Term Description Entries
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D007475 Ion Exchange Resins High molecular weight, insoluble polymers which contain functional groups that are capable of undergoing exchange reactions (ION EXCHANGE) with either cations or anions. Ion Exchange Resin,Exchange Resin, Ion,Exchange Resins, Ion,Resin, Ion Exchange,Resins, Ion Exchange
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011479 Protamines A group of simple proteins that yield basic amino acids on hydrolysis and that occur combined with nucleic acid in the sperm of fish. Protamines contain very few kinds of amino acids. Protamine sulfate combines with heparin to form a stable inactive complex; it is used to neutralize the anticoagulant action of heparin in the treatment of heparin overdose. (From Merck Index, 11th ed; Martindale, The Extra Pharmacopoeia, 30th ed, p692) Protamine,Protamine Sulfate,Protamine Chloride,Chloride, Protamine,Sulfate, Protamine
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses

Related Publications

D L Schatz, and R H Sheppard, and G Steiner, and C S Chandarlapaty, and G A de Veber
May 1982, Lancet (London, England),
D L Schatz, and R H Sheppard, and G Steiner, and C S Chandarlapaty, and G A de Veber
November 1983, Clinical endocrinology,
D L Schatz, and R H Sheppard, and G Steiner, and C S Chandarlapaty, and G A de Veber
March 1976, Clinica chimica acta; international journal of clinical chemistry,
D L Schatz, and R H Sheppard, and G Steiner, and C S Chandarlapaty, and G A de Veber
January 1996, Annals of internal medicine,
D L Schatz, and R H Sheppard, and G Steiner, and C S Chandarlapaty, and G A de Veber
March 1972, The Journal of clinical endocrinology and metabolism,
D L Schatz, and R H Sheppard, and G Steiner, and C S Chandarlapaty, and G A de Veber
May 1998, Clinical chemistry,
D L Schatz, and R H Sheppard, and G Steiner, and C S Chandarlapaty, and G A de Veber
May 1971, The Journal of clinical endocrinology and metabolism,
D L Schatz, and R H Sheppard, and G Steiner, and C S Chandarlapaty, and G A de Veber
January 1967, Scandinavian journal of clinical and laboratory investigation. Supplementum,
D L Schatz, and R H Sheppard, and G Steiner, and C S Chandarlapaty, and G A de Veber
February 1969, Metabolism: clinical and experimental,
D L Schatz, and R H Sheppard, and G Steiner, and C S Chandarlapaty, and G A de Veber
July 1971, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!